Laborie Begins ENDURE 1 Study with Optilume for Ureteric Strictures Laborie Medical Technologies has marked a significant milestone with the launch of the ENDURE 1 study, aiming to evaluate its Optilume Drug-Coated Balloon for treating ureteric strictures.

Laborie Begins ENDURE 1 Study with Optilume for Ureteric Strictures #United_States #Portsmouth #Optilume #Laborie #Ureteric_Stricture

Laborie's Optilume® Drug-Coated Balloon Secures New Coverage from BCBSM for Patients Laborie Medical Technologies' Optilume® Drug-Coated Balloon has received extended coverage from Blue Cross Blue Shield of Michigan, enhancing treatment options for patients.

Laborie's Optilume® Drug-Coated Balloon Secures New Coverage from BCBSM for Patients #United_States #Portsmouth #Optilume #Laborie_Medical #BCBSM

Revolutionary Study Validates Durability of Optilume® Drug-Coated Balloon for Urethral Treatment A recent study confirms the long-term effectiveness of the Optilume® Drug-Coated Balloon in treating recurrent urethral strictures, showcasing significant patient outcomes over three years.

Revolutionary Study Validates Durability of Optilume® Drug-Coated Balloon for Urethral Treatment #USA #Optilume #Portsmouth,_New_Hampshire #Laborie_Medical #Urethral_Strictures

Optilume Drug-Coated Balloon Demonstrates Long-Term Success in Treating Urethral Strictures Over Five Years Laborie's Optilume Drug-Coated Balloon has shown impressive long-term efficacy in treating urethral strictures, demonstrating significant patient outcomes after five years.

Optilume Drug-Coated Balloon Demonstrates Long-Term Success in Treating Urethral Strictures Over Five Years #United_States #Optilume #Laborie #Urethral_Stricture #Portsmouth,_NH